Petros Grivas, MD, PhD, FASCO sits down with Brittany Barber, MD, MSc, FRCSC, associate professor, division leader and ...

We make promising new treatments available to you through studies called clinical trials led by Fred Hutch physicians and researchers. Many of these trials at Fred Hutch have led to FDA-approved ...

Heather Cheng, MD, PhD, clinical director of cancer genetics programs at Fred Hutch Cancer Center, was recently named the ...

On Saturday, Aug. 8, thousands gathered at Obliteride, Fred Hutch’s summer ride and 5K walk/run fundraiser to take action and ...

Small cell lung cancer, or SCLC, is fraught with challenges. Patients are often diagnosed late so outcomes are poor; therapeutic advances have stalled due to lackluster funding and the disease, ...

Fred Hutch cancer metabolism expert Dr. Lucas Sullivan discovered that feeding NRF2-mutated tumors too much of a nutrient they crave makes them vulnerable to slower growth and cell death, a ...

Eight Fred Hutch researchers receive nearly $1 million to advance projects with industry partnership potential SEATTLE — July 14, 2026 — Eight researchers at Fred Hutch Cancer Center will receive a ...

More than 150 lung cancer researchers, clinicians and patient advocates from around the country gathered at Fred Hutch Cancer Center in Seattle last week for a two-day working meeting of the Fred ...

Since its earliest days, Fred Hutch Cancer Center's story has been closely tied to bone marrow transplantation. E. Donnall Thomas, MD, Fred Hutch’s first director of medical oncology, pioneered this ...

Veena Shankaran, MD, MS, co-director of the Hutchinson Institute for Cancer Outcomes Research (HICOR) at Fred Hutch Cancer Center, has been awarded the newly established Lert Family Endowed Chair. A ...

As researchers in the laboratories and clinics of Fred Hutch Cancer Center strive to develop tomorrow’s cures for cancer, many are also pursuing innovative ways to improve the experience of people ...